NCT07004140

Brief Summary

The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can show changes in the brain within the first day of a stroke due to a blocked blood vessel or bleeding in the brain. The main question it aims to answer is: • Can FCI identify brain tissue that might recover within the first few hours after a stroke begins? Participants will undergo a standard MRI scan and an FCI scan, as soon as possible after hospital admission. Participants who have had a blocked blood vessel will also provide a blood sample and will have a follow up visit at 30 days for repeat of both scans and providing another blood sample.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

September 16, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

May 26, 2025

Last Update Submit

January 26, 2026

Conditions

Keywords

StrokeField-Cycling ImagingFCI

Outcome Measures

Primary Outcomes (1)

  • Agreement between extent of ischaemic stroke at-risk tissue/infarct core obtained from FCI dispersion maps and 3T MRI modalities at baseline

    Receiver operator curves (ROC) curves comparing extent of at-risk tissue/infarct core obtained from FCI dispersion maps and from 3T MRI modalities at baseline at stroke onset.

    Baseline at stroke onset

Secondary Outcomes (3)

  • Agreement between extent of haemorrhagic volume obtained from FCI dispersion maps and 3T MRI modalities at baseline

    Baseline at stroke onset

  • Agreement of infarct core volume measurements obtained from FCI and 3T MRI at day 30 in ischaemic stroke patients

    30 days after stroke onset

  • Agreement between T1 dispersion curve measurements obtained from in vivo clot in large intracerebral vessels and clot formed in vitro.

    At baseline and 30 days after stroke onset

Study Arms (2)

Ischaemic stroke

Ischaemic stroke patients within 24 hours from symptom onset

Other: 3T MRI research scanOther: Field-Cycling Imaging research scanOther: Follow up 3T MRI research scanOther: Follow up Field-Cycling Imaging research scanOther: Blood samples for clotting experiments in vitro

Haemorrhagic stroke

Patients with primary intracerebral haemorrhage within 24 hours from symptom onset

Other: 3T MRI research scanOther: Field-Cycling Imaging research scan

Interventions

Day 30 FCI scan

Ischaemic stroke

Thrombi from whole blood from ischaemic stroke patients will be formed and examined using bench top nuclear magnetic resonance (NMR) assays. At baseline and 30 days after stroke onset.

Ischaemic stroke

Baseline MRI scan

Haemorrhagic strokeIschaemic stroke

Day 30 3T MRI scan

Ischaemic stroke

Baseline FCI scan

Haemorrhagic strokeIschaemic stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with acute stroke admitted to Aberdeen Royal Infirmary.

You may qualify if:

  • Acute stroke (\<24 hours from symptom onset).
  • NIHSS ≥4 and \<25 with cortical involvement and/or large vessel occlusion on baseline imaging.
  • Able to undergo 3T and FCI MRI \<24h of onset.
  • With or without thrombolysis.

You may not qualify if:

  • Contraindications to MRI.
  • Medically unstable.
  • Unable to comprehend or comply with instructions regarding scanning
  • Prior mRS of \>3.
  • Identified for thrombectomy.
  • Non-stroke pathology or previous cortical infarct on CT scan \> 1/3 of middle cerebral artery territory.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Aberdeen

Aberdeen, AB25 2ZD, United Kingdom

RECRUITING

Related Publications (2)

  • Mallikourti V, Ross PJ, Maier O, Guzman-Gutierrez G, Franko E, Lurie DJ, Broche LM, Macleod MJ. Field-Cycling MRI for Identifying Minor Ischemic Stroke Below 0.2 T. Radiology. 2024 Aug;312(2):e232972. doi: 10.1148/radiol.232972.

    PMID: 39189899BACKGROUND
  • Senn N, Ross PJ, Ayde R, Mallikourti V, Krishna A, James C, de Vries CF, Broche LM, Waiter GD, MacLeod MJ. Field-cycling imaging yields repeatable brain R1 dispersion measurement at fields strengths below 0.2 Tesla with optimal fitting routine. MAGMA. 2025 Jul;38(3):465-474. doi: 10.1007/s10334-025-01230-w. Epub 2025 Feb 15.

    PMID: 39955477BACKGROUND

MeSH Terms

Conditions

Stroke

Interventions

Blood Specimen CollectionIn Vitro Techniques

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Mary Joan MacLeod, PhD

CONTACT

Gordon D Waiter, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2025

First Posted

June 4, 2025

Study Start

September 16, 2025

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

January 27, 2026

Record last verified: 2026-01

Locations